Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib

Cancer Chemotherapy and Pharmacology- Germany

doi 10.1007/s00280-011-1785-7

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Complete Molecular Response Induced by Nilotinib in a Patient Previously Treated With Imatinib, Nilotinib and Dasatinib

Clinical Management Issues
MedicineAccountingManagementBusiness
2015English

Pancreatic Enzyme Elevation in Chronic Myeloid Leukemia Patients Treated With Nilotinib After Imatinib Failure

Haematologica
Hematology
2009English

Side-Effects From Imatinib Treatment of Advanced GIST–associated With a Better Outcome

journal of Cancer Therapeutics and Research
2012English

Mitotic Count and Estimation of the Risk of GIST Recurrence in Patients Treated With Preoperative Imatinib

Clinical Oncology and Research
2019English

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

PLoS ONE
Multidisciplinary
2012English

Nilotinib Übertrifft Imatinib in Der First-Line Weiterhin

Info Onkologie
2011German

Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib and Best Supportive Care in Previously Treated Renal Cell Carcinoma: A Systematic Review and Economic Evaluation

Health Technology Assessment
MedicineHealth Policy
2018English

Neoadjuvant Imatinib for Borderline Resectable GIST

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy